
Investors should prioritize Microsoft (MSFT) as it leverages its "chip-to-model" vertical integration to offer frontier-level AI at costs 10x lower than competitors, positioning it to dominate enterprise budgets. In the hardware sector, SK Hynix remains a high-conviction long-term play as it doubles manufacturing capacity to address a structural shortage in High Bandwidth Memory (HBM) that could last until 2030. For those seeking efficiency gains, look toward the Energy and Healthcare sectors as they integrate Anthropic’s advanced cyber-defensive tools through the Project Glasswing expansion. OpenAI’s new industry-specific plugins for Investment Banking and Public Equity signal an aggressive move into high-value financial services that investors should monitor for immediate productivity shifts. Finally, focus on "middleware" platforms that enable the rapid deployment of Agentic Systems, as the market shifts from simple chatbots to AI that performs autonomous business tasks.
Anthropic is a leading AI research lab currently navigating a complex regulatory environment while rolling out high-end cyber-capable models. The discussion focused on their Mythos model and the Project Glasswing initiative.
OpenAI is positioning its Codex platform as the "factory redesign" for knowledge work, moving beyond simple chat interfaces to integrated agentic systems.
Microsoft is pivoting its strategy toward cost optimization and in-house model development to reduce reliance on third-party providers and lower the "AI tax" for enterprises.
The South Korean chipmaker is responding to a structural shortage in the AI supply chain, specifically regarding memory.

By Nathaniel Whittemore
A daily news analysis show on all things artificial intelligence. NLW looks at AI from multiple angles, from the explosion of creativity brought on by new tools like Midjourney and ChatGPT to the potential disruptions to work and industries as we know them to the great philosophical, ethical and practical questions of advanced general intelligence, alignment and x-risk.